SMCHD1 and facioscapulohumeral muscular dystrophy: A recent paper by Sacconi et al.[76], showing that mutations in the FSHD2 gene SMCHD1 act as a disease modifier in FSHD1 families suggests that epigenetic variation may, at least in part, underlie the clinical variability of FSHD.